Merck & Co., Inc. (1MRKX)
MTA
Closed
Aug 21, 2026
Day's Range
126.5252 wk Range
66.50Overview - 1MRKX - Merck & Co., Inc.
Key Statistics
Valuation
Enterprise Value
317.02B
P/E (Trailing)
‪125.16‬
PEG Ratio
‪-0.95‬
Price / Sales (TTM)
‪4.87‬
Price / Book
‪9.04‬
EV / EBITDA
‪12.85‬
Profitability
Gross Margin
‪73.53%‬
Profit Margin
‪4.76%‬
Operating Margin
‪-0.24%‬
Return on Assets
‪11.86%‬
Return on Equity
‪6.96%‬
Ownership
Shares Outstanding
2.46B
Float
2.46B
Held by Insiders
‪0.05%‬
Held by Institutions
‪82.72%‬
Price stats
Beta
‪0.21‬
50-Day Avg
‪111.00‬
200-Day Avg
‪99.82‬
Dividends
Payout Ratio
‪268.80%‬
Frequency
Quarterly
Market Cap - 1MRKX - Merck & Co., Inc.
Peers - 1MRKX - Merck & Co., Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on MTA.
- 1MRKXMTAMerck & Co., Inc.240.41BMarket Cap+44.15%52-week change119.54P/E (Trailing)‪4.76%‬Profit Margin
- 1LLYMTAEli Lilly and Company853.56BMarket Cap+44.62%52-week change42.34P/E (Trailing)‪33.52%‬Profit Margin
- 1JNJMTAJohnson & Johnson428.46BMarket Cap+35.82%52-week change31.30P/E (Trailing)‪21.48%‬Profit Margin
- 1ABBVMTAAbbVie Inc.344.57BMarket Cap+21.59%52-week change74.43P/E (Trailing)‪9.80%‬Profit Margin
- 1ROMTARoche Holding AG294.63BMarket Cap+26.89%52-week change24.52P/E (Trailing)‪19.60%‬Profit Margin
- 1NOVNMTANovartis AG238.75BMarket Cap+22.16%52-week change24.02P/E (Trailing)‪22.50%‬Profit Margin
- 1AMGNMTAAmgen Inc.155.67BMarket Cap+34.30%52-week change27.31P/E (Trailing)‪22.95%‬Profit Margin
Profile Summary - 1MRKX - Merck & Co., Inc.
About
Merck & Co., Inc. is a global healthcare company focused on discovering, developing, manufacturing, and commercializing prescription medicines, vaccines, biologic therapies, and animal health products. Its pharmaceutical business serves major therapeutic areas including oncology, infectious diseases, immunology,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
